These patents were previously owned by Infigen and cover a wide range of technologies including for Pharming relevant elements of nuclear transfer, which is an essential step in
Bio-Kinetic, an early clinical research organization with a 240-bed phase I facility, will retain its name and become a wholly-owned subsidiary of QPS Holdings. QPS and Bio-Kinetic’s collective
Dov 21,947 is company’s lead triple reuptake inhibitor, or TRIP, for the treatment of depression and obesity. The clinical trial, which will randomize approximately 200 patients, will evaluate
Ongoing mid-stage clinical trials of Xcytrin (motexafin gadolinium) are substantially complete and the company intends to partner or out-license the drug for further development. Company will also reduce
CryoCor is requesting that the ITC initiate an investigation and issue an exclusion order to bar the importation into the US of infringing CryoCath cryoablation products. CryoCor’s complaint
The company initially recalled nine lots of heparin sodium injection multi-dose vials on January 17, 2008 as a precautionary measure due to a higher than usual number of
MEI will provide Mobile Diagnostic Centers access to a variety of mobile imaging PET/CT manufacturers, guaranteeing the best fit for Mobile Diagnostic Centers specific imaging equipment needs. Michael
Each unit is comprised of one common share of the company and one-half of one share purchase warrant. Each whole warrant entitles the holder thereof to purchase one
Researchers at the James Graham Brown Cancer Center, University of Louisville, Kentucky, studied the synergistic effects of Imprime PGG in combination with Avastin in a xenograft mouse model
Funded by Boston Millennia Partners and private investors, to date, the company has raised approximately $31 million of equity capital. Steve Ek, COO of Arthrosurface, said: “The series
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.